Home Page
Trending Articles
-
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
J Clin Oncol. 2024. PMID: 39173098
-
Acetate enables metabolic fitness and cognitive performance during sleep disruption.
Cell Metab. 2024. PMID: 39163862
-
These labs have prepared for a big earthquake - will it be enough?
Nature. 2024. PMID: 39155315 No abstract available.